-
3
-
-
51349097613
-
Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences
-
Kersemans V, Cornelissen B, Minden MD, Brandwein J, Reilly RM. Drug-resistant AML cells and primary AML specimens are killed by 111In-anti-CD33 monoclonal antibodies modified with nuclear localizing peptide sequences. J Nucl Med 2008;49(9):1546-54.
-
(2008)
J Nucl Med
, vol.49
, Issue.9
, pp. 1546-1554
-
-
Kersemans, V.1
Cornelissen, B.2
Minden, M.D.3
Brandwein, J.4
Reilly, R.M.5
-
4
-
-
12344298622
-
The anthracycline antibiotics: antitumor drugs that alter chromatin structure
-
Rabbani A, Finn RM, Ausio J. The anthracycline antibiotics: antitumor drugs that alter chromatin structure. Bioessays 2005;27(1):50-6.
-
(2005)
Bioessays
, vol.27
, Issue.1
, pp. 50-56
-
-
Rabbani, A.1
Finn, R.M.2
Ausio, J.3
-
5
-
-
74549195798
-
Current and emerging therapies for acute myeloid leukemia
-
Robak T, Wierzbowska A. Current and emerging therapies for acute myeloid leukemia. Clin Ther 2009;31 Pt 2:2349-70.
-
(2009)
Clin Ther
, vol.31
, Issue.PART 2
, pp. 2349-2370
-
-
Robak, T.1
Wierzbowska, A.2
-
6
-
-
36849050776
-
Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer
-
Bardi E, Bobok I, Oláh AV, Kappelmayer J, Kiss C. Anthracycline antibiotics induce acute renal tubular toxicity in children with cancer. Pathol Oncol Res 2007;13(3):249-53.
-
(2007)
Pathol Oncol Res
, vol.13
, Issue.3
, pp. 249-253
-
-
Bardi, E.1
Bobok, I.2
Oláh, A.V.3
Kappelmayer, J.4
Kiss, C.5
-
7
-
-
33748118943
-
Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells
-
Gu C, Ye T, Wells RA. Synergistic effects of troglitazone in combination with cytotoxic agents in acute myelogenous leukaemia cells. Leuk Res 2006;30(11):1447-51.
-
(2006)
Leuk Res
, vol.30
, Issue.11
, pp. 1447-1451
-
-
Gu, C.1
Ye, T.2
Wells, R.A.3
-
8
-
-
25444480003
-
Programmed cell death via mitochondria: different modes of dying
-
Bras M, Queenan B, Susin SA. Programmed cell death via mitochondria: different modes of dying. Biochemistry (Mosc) 2005;70(2):231-9.
-
(2005)
Biochemistry (Mosc)
, vol.70
, Issue.2
, pp. 231-239
-
-
Bras, M.1
Queenan, B.2
Susin, S.A.3
-
9
-
-
0030026865
-
Bax-independent inhibition of apoptosis by Bcl-XL
-
Cheng EH, Levine B, Boise LH, Thompson CB, Hardwick JM. Bax-independent inhibition of apoptosis by Bcl-XL. Nature 1996;379(6565):554-6.
-
(1996)
Nature
, vol.379
, Issue.6565
, pp. 554-556
-
-
Cheng, E.H.1
Levine, B.2
Boise, L.H.3
Thompson, C.B.4
Hardwick, J.M.5
-
10
-
-
0033965412
-
Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins
-
Lutz RJ. Role of the BH3 (Bcl-2 homology 3) domain in the regulation of apoptosis and Bcl-2-related proteins. Biochem Soc Trans 2000;28(2):51-6.
-
(2000)
Biochem Soc Trans
, vol.28
, Issue.2
, pp. 51-56
-
-
Lutz, R.J.1
-
11
-
-
20444486559
-
An inhibitor of Bcl-2 family proteins induces regression of solid tumours
-
Oltersdorf T, Elmore SW, Shoemaker AR, Armstrong RC, Augeri DJ, Belli BA, et al. An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature 2005;435(7042):677-81.
-
(2005)
Nature
, vol.435
, Issue.7042
, pp. 677-681
-
-
Oltersdorf, T.1
Elmore, S.W.2
Shoemaker, A.R.3
Armstrong, R.C.4
Augeri, D.J.5
Belli, B.A.6
-
12
-
-
77953926671
-
Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy
-
Varin E, Denoyelle C, Brotin E, Meryet-Figuiere M, Giffard F, Abeilard E, et al. Downregulation of Bcl-xL and Mcl-1 is sufficient to induce cell death in mesothelioma cells highly refractory to conventional chemotherapy. Carcinogenesis 2010;31(6):984-93.
-
(2010)
Carcinogenesis
, vol.31
, Issue.6
, pp. 984-993
-
-
Varin, E.1
Denoyelle, C.2
Brotin, E.3
Meryet-Figuiere, M.4
Giffard, F.5
Abeilard, E.6
-
13
-
-
84872678419
-
Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells
-
Akagi H, Higuchi H, Sumimoto H, Igarashi T, Kabashima A, Mizuguchi H, et al. Suppression of myeloid cell leukemia-1 (Mcl-1) enhances chemotherapy-associated apoptosis in gastric cancer cells. Gastric Cancer 2013;16(1):100-10.
-
(2013)
Gastric Cancer
, vol.16
, Issue.1
, pp. 100-110
-
-
Akagi, H.1
Higuchi, H.2
Sumimoto, H.3
Igarashi, T.4
Kabashima, A.5
Mizuguchi, H.6
-
14
-
-
63149129655
-
Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy
-
Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009;15(4):1126-32.
-
(2009)
Clin Cancer Res
, vol.15
, Issue.4
, pp. 1126-1132
-
-
Kang, M.H.1
Reynolds, C.P.2
-
15
-
-
2442464889
-
Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks
-
Pommier Y, Sordet O, Antony S, Hayward RL, Kohn KW. Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks. Oncogene 2004;23(16):2934-49.
-
(2004)
Oncogene
, vol.23
, Issue.16
, pp. 2934-2949
-
-
Pommier, Y.1
Sordet, O.2
Antony, S.3
Hayward, R.L.4
Kohn, K.W.5
-
16
-
-
37249003222
-
The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin
-
Witham J, Valenti MR, De-Haven-Brandon AK, Vidot S, Eccles SA, Kaye SB, et al. The Bcl-2/Bcl-XL family inhibitor ABT-737 sensitizes ovarian cancer cells to carboplatin. Clin Cancer Res 2007;13(23):7191-8.
-
(2007)
Clin Cancer Res
, vol.13
, Issue.23
, pp. 7191-7198
-
-
Witham, J.1
Valenti, M.R.2
De-Haven-Brandon, A.K.3
Vidot, S.4
Eccles, S.A.5
Kaye, S.B.6
-
17
-
-
42049091619
-
Unique biology of Mcl-1: therapeutic opportunities in cancer
-
Warr MR, Shore GC. Unique biology of Mcl-1: therapeutic opportunities in cancer. Curr Mol Med 2008;8(2):138-47.
-
(2008)
Curr Mol Med
, vol.8
, Issue.2
, pp. 138-147
-
-
Warr, M.R.1
Shore, G.C.2
-
18
-
-
0021118703
-
Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors
-
Chou TC, Talalay P. Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv Enzyme Regul 1984;22:27-55.
-
(1984)
Adv Enzyme Regul
, vol.22
, pp. 27-55
-
-
Chou, T.C.1
Talalay, P.2
-
19
-
-
23644455476
-
Drug therapy for acute myeloid leukemia
-
Tallman MS, Gilliland DG, Rowe JM. Drug therapy for acute myeloid leukemia. Blood 2005;106(4):1154-63.
-
(2005)
Blood
, vol.106
, Issue.4
, pp. 1154-1163
-
-
Tallman, M.S.1
Gilliland, D.G.2
Rowe, J.M.3
-
20
-
-
84863082940
-
Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737
-
Lucas KM, Mohana-Kumaran N, Lau D, Zhang XD, Hersey P, Huang DC, et al. Modulation of NOXA and MCL-1 as a strategy for sensitizing melanoma cells to the BH3-mimetic ABT-737. Clin Cancer Res 2012;18(3):783-95.
-
(2012)
Clin Cancer Res
, vol.18
, Issue.3
, pp. 783-795
-
-
Lucas, K.M.1
Mohana-Kumaran, N.2
Lau, D.3
Zhang, X.D.4
Hersey, P.5
Huang, D.C.6
-
21
-
-
33846674886
-
Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation
-
Chen S, Dai Y, Harada H, Dent P, Grant S. Mcl-1 down-regulation potentiates ABT-737 lethality by cooperatively inducing Bak activation and Bax translocation. Cancer Res 2007;67(2):782-91.
-
(2007)
Cancer Res
, vol.67
, Issue.2
, pp. 782-791
-
-
Chen, S.1
Dai, Y.2
Harada, H.3
Dent, P.4
Grant, S.5
-
22
-
-
34249996230
-
'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737
-
Lin X, Morgan-Lappe S, Huang X, Li L, Zakula DM, Vernetti LA, et al. 'Seed' analysis of off-target siRNAs reveals an essential role of Mcl-1 in resistance to the small-molecule Bcl-2/Bcl-XL inhibitor ABT-737. Oncogene 2007;26(27):3972-9.
-
(2007)
Oncogene
, vol.26
, Issue.27
, pp. 3972-3979
-
-
Lin, X.1
Morgan-Lappe, S.2
Huang, X.3
Li, L.4
Zakula, D.M.5
Vernetti, L.A.6
-
23
-
-
33847061737
-
Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737
-
Tahir SK, Yang X, Anderson MG, Morgan-Lappe SE, Sarthy AV, Chen J, et al. Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737. Cancer Res 2007;67(3):1176-83.
-
(2007)
Cancer Res
, vol.67
, Issue.3
, pp. 1176-1183
-
-
Tahir, S.K.1
Yang, X.2
Anderson, M.G.3
Morgan-Lappe, S.E.4
Sarthy, A.V.5
Chen, J.6
-
24
-
-
33750834023
-
The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized
-
Van Delft MF, Wei AH, Mason KD, Vandenberg CJ, Chen L, Czabotar PE, et al. The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized. Cancer Cell 2006;10(5):389-99.
-
(2006)
Cancer Cell
, vol.10
, Issue.5
, pp. 389-399
-
-
Van Delft, M.F.1
Wei, A.H.2
Mason, K.D.3
Vandenberg, C.J.4
Chen, L.5
Czabotar, P.E.6
-
25
-
-
70449635154
-
ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts
-
Ugarenko M, Nudelman A, Rephaeli A, Kimura K, Phillips DR, Cutts SM. ABT-737 overcomes Bcl-2 mediated resistance to doxorubicin-DNA adducts. Biochem Pharmacol 2010;79(3):339-49.
-
(2010)
Biochem Pharmacol
, vol.79
, Issue.3
, pp. 339-349
-
-
Ugarenko, M.1
Nudelman, A.2
Rephaeli, A.3
Kimura, K.4
Phillips, D.R.5
Cutts, S.M.6
|